-
ECL Western Blotting Substrate: Practical Guide
2026-09-09
ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection on immunoblots. It is intended for HRP-linked Western blot workflows using X-ray film or CCD imaging, not for fluorescent or radioisotopic assays, and the prepared reagent should be used promptly.
-
PRINT: RNA-Mediated Safe-Harbor Transgene Insertion
2026-09-09
The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins and target-primed reverse transcription to insert transgenes at a multicopy human safe-harbor locus. Its reported efficiency, direct genomic cDNA synthesis, and absence of donor DNA establish a mechanistically distinct alternative to conventional CRISPR repair and viral delivery, while leaving important questions about cargo range, cell-type transferability, and long-term genome behavior.
-
SB203580 and p38α: Assay Logic Beyond Inhibition
2026-09-08
SB203580 is more than an ATP-competitive p38 MAPK inhibitor: it is a tool for separating kinase output from activation-loop phosphorylation and phosphatase control. This guide translates recent p38α conformational research into practical assay design, controls, and interpretation strategies.
-
tiRNA: Controllable Gene Silencing by Translation Inhibition
2026-09-08
The reference study introduces translation inhibition RNA (tiRNA), an aptamer-based steric-blocking design that suppresses selected mRNA translation without degrading the transcript. Its modular targeting strategy, siRNA-comparable activity, and neutralizing-strand reversibility suggest a controllable framework for regulating proteins whose expression must be reduced temporarily or selectively.
-
Cy5-UTP: From RNA Probe to Trafficking Readout
2026-09-07
Cy5-UTP enables direct, far-red RNA visualization through T7-driven in vitro transcription RNA labeling. This guide connects RNA probe synthesis with the interpretive controls needed to distinguish RNA localization, nanoparticle trafficking, and functional delivery.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-09-05
K1221 provides an HRP-labeled secondary reagent for detecting mouse IgG in Western blotting, ELISA, IHC, and ICC workflows. It should be optimized against the primary antibody, specimen, substrate, and instrument rather than used with an assumed universal dilution or as evidence of cross-species reactivity.
-
Ibuprofen Workflows for Cell and Protein Assays
2026-09-05
Build reproducible Ibuprofen experiments that connect COX inhibition with proliferation, apoptosis, and cell-cycle phenotypes in colon cancer research. An orthogonal protein-binding workflow, inspired by mechanistic work on mubritinib, adds a practical route for separating cellular activity from exposure and albumin-interaction effects.
-
PD-L1–IL-6 Crosstalk in Primary Sclerosing Cholangitis
2026-09-04
A 2026 JHEP Reports pre-proof applies spatial proteomics and cell-cell cross-talk analysis to human primary sclerosing cholangitis, identifying a spatially organized relationship between PD-L1 and IL-6 at the epithelial–immune interface. The study provides a disease-relevant framework for distinguishing inflammatory signaling niches from tissue-wide molecular averages and for designing mechanistic follow-up experiments.
-
RIPostC, Ketone Bodies, and Ferroptosis in Stroke
2026-09-04
A 2024 ACS Chemical Neuroscience study identifies ketone-body production as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. Rat and HT22-cell experiments connect improved energy metabolism with reduced lipid peroxidation, preserved GPX4, lower ACSL4 expression, and diminished iron accumulation, while also showing why ketone-body mixtures should not be equated automatically with BHBA-specific effects.
-
2'3'-cGAMP (sodium salt) in Cell Assays
2026-09-03
Learn how 2'3'-cGAMP (sodium salt), SKU B8362, can serve as a controlled STING-pathway perturbation when viability, proliferation, and cytotoxicity results are difficult to interpret. This scenario-based guide connects formulation, assay controls, protocol design, and recent evidence on cGAS-STING activation.
-
Cefoperazone Sodium Salt: Assay Design and Insight
2026-09-03
Explore how Cefoperazone sodium salt connects β-lactamase stability, endpoint selection, chemical handling, and biliary tract infection research. This evidence-driven guide translates comparative microbiology into more reproducible antimicrobial assays.
-
Myriocin: Serine Palmitoyltransferase Inhibitor
2026-09-02
Myriocin is a potent serine palmitoyltransferase inhibitor that blocks the first step of de novo sphingolipid biosynthesis. Evidence from cell assays, melanoma models, and a 24-week high-AGE mouse study supports its use in sphingolipid metabolism research, cancer research, and metabolic signaling studies.
-
Glucocorticoids, Kv2.1, and CaV1.2 Calcium Signals
2026-09-02
This 2024 Journal of Neuroscience study identifies a rapid, nongenomic pathway through which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons. The mechanism links reduced cAMP/PKA activity to endocytosis of Kv2.1 channel clusters, which in turn promotes loss of surface-associated CaV1.2 channels and dampens neuronal calcium spikes.
-
PNU 74654: Wnt Pathway Research Workflows
2026-09-01
PNU 74654 provides a reversible small-molecule approach for probing Wnt/β-catenin signaling in cancer research, stem cell research, and progenitor-cell differentiation models. This guide translates findings from a skeletal-muscle adipogenesis study into practical dosing, readout, optimization, and troubleshooting workflows while separating pathway-level hypotheses from validated product-specific evidence.
-
Bestatin and Angiotensin Processing in Rat Brain
2026-08-31
Harding and Felix used iontophoretic pharmacology and single-neuron recording to test whether angiotensin II must be converted to angiotensin III before activating rat brain neurons. The contrasting effects of bestatin, amastatin, and Sar1-modified angiotensin peptides provide mechanistic evidence for precursor processing, while also defining important limits for transferring these findings to other aminopeptidase-driven models.